$8.52
7.59% yesterday
Nasdaq, Feb 28, 08:19 pm CET
ISIN
US7458481014
Symbol
LUNG

ProLung Inc Target price 2025 - Analyst rating & recommendation

ProLung Inc Classifications & Recommendation:

Buy
67%
Hold
33%

ProLung Inc Price Target

Target Price $11.67
Price $8.62
Potential
Number of Estimates 6
6 Analysts have issued a price target ProLung Inc 2026 . The average ProLung Inc target price is $11.67. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 6 analysts: 4 Analysts recommend ProLung Inc to buy, 2 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the ProLung Inc stock has an average upside potential 2026 of . Most analysts recommend the ProLung Inc stock at Purchase.

Sales and Margin forecast 2025, 2026 to 2029

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Revenue Million $ 83.79 100.14
22.00% 19.51%
EBITDA Margin -64.91% -48.34%
25.68% 25.53%
Net Margin -68.38% -61.19%
26.23% 10.52%

6 Analysts have issued a sales forecast ProLung Inc 2025 . The average ProLung Inc sales estimate is

$100m
Unlock
. This is
19.51% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$116m 38.68%
Unlock
, the lowest is
$96.0m 14.57%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2024 $83.8m 22.00%
2025
$100m 19.51%
Unlock
2026
$115m 14.52%
Unlock
2027
$137m 19.66%
Unlock
2028
$166m 20.75%
Unlock
2029
$189m 14.30%
Unlock

6 Analysts have issued an ProLung Inc EBITDA forecast 2025. The average ProLung Inc EBITDA estimate is

$-48.4m
Unlock
. This is
11.00% higher
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$-33.8m 37.86%
Unlock
, the lowest is
$-59.9m 10.20%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2024 $-54.4m 9.33%
2025
$-48.4m 11.00%
Unlock
2026
$-44.3m 8.57%
Unlock
2027
$-37.6m 15.10%
Unlock
2028
$-18.2m 51.70%
Unlock
2029
$15.6m 185.95%
Unlock

EBITDA Margin

2024 -64.91% 25.68%
2025
-48.34% 25.53%
Unlock
2026
-38.59% 20.17%
Unlock
2027
-27.38% 29.05%
Unlock
2028
-10.95% 60.01%
Unlock
2029
8.24% 175.25%
Unlock

1 Analyst has issued a net profit forecast ProLung Inc 2025 . The average ProLung Inc net profit estimate is

$-61.3m
Unlock
. This is
6.95% lower
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$-61.3m 6.95%
Unlock
, the lowest is
$-61.3m 6.95%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2024 $-57.3m 10.00%
2025
$-61.3m 6.95%
Unlock
2026
$-53.7m 12.34%
Unlock
2027
$-37.4m 30.38%
Unlock
2028
$-32.2m 13.82%
Unlock
2029
$-21.5m 33.32%
Unlock

Net Margin

2024 -68.38% 26.23%
2025
-61.19% 10.52%
Unlock
2026
-46.84% 23.45%
Unlock
2027
-27.26% 41.80%
Unlock
2028
-19.45% 28.65%
Unlock
2029
-11.34% 41.70%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Earnings Per Share $ -1.44 -1.54
10.00% 6.94%
P/E negative
EV/Sales 2.97

1 Analysts have issued a ProLung Inc forecast for earnings per share. The average ProLung Inc <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is

$-1.54
Unlock
. This is
6.94% lower
Unlock
than earnings per share in the financial year 2024. The highest <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS forecast is
$-1.54 6.94%
Unlock
, the lowest is
$-1.54 6.94%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2024 $-1.44 10.00%
2025
$-1.54 6.94%
Unlock
2026
$-1.35 12.34%
Unlock
2027
$-0.94 30.37%
Unlock
2028
$-0.81 13.83%
Unlock
2029
$-0.54 33.33%
Unlock

P/E ratio

Current -5.98 11.28%
2025
-5.60 6.35%
Unlock
2026
-6.39 14.11%
Unlock
2027
-9.17 43.51%
Unlock
2028
-10.64 16.03%
Unlock
2029
-15.96 50.00%
Unlock

Based on analysts' sales estimates for 2025, the ProLung Inc stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of

and an <a href=https://blog.stocksguide.com/knowledge/price-sales-ratio-simply-explained>P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 3.55 27.85%
2025
2.97 16.23%
Unlock
2026
2.60 12.68%
Unlock
2027
2.17 16.43%
Unlock
2028
1.80 17.18%
Unlock
2029
1.57 12.51%
Unlock

P/S ratio

Current 4.09 32.10%
2025
3.43 16.32%
Unlock
2026
2.99 12.68%
Unlock
2027
2.50 16.43%
Unlock
2028
2.07 17.18%
Unlock
2029
1.81 12.52%
Unlock

Current ProLung Inc Upgrades & Downgrades Beta

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
Citigroup Locked ➜ Locked Locked Dec 11 2024
Wells Fargo Locked ➜ Locked Locked Dec 11 2024
Stifel Locked ➜ Locked Locked Oct 31 2024
Analyst Rating Date
Locked
Citigroup: Locked ➜ Locked
Dec 11 2024
Locked
Wells Fargo: Locked ➜ Locked
Dec 11 2024
Locked
Stifel: Locked ➜ Locked
Oct 31 2024

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today